Publication | Closed Access
FDA Approval of Paroxetine for Menopausal Hot Flushes
73
Citations
3
References
2014
Year
Menopausal Vasomotor SymptomsFda Advisory CommitteeMedicinePharmacoepidemiologyGynecologyMenopausal Hormone TherapyFda ApprovalPharmacotherapyMenopauseSide EffectHormone TherapyPostreproductive HealthEndocrinologyPharmacologyHormone-free ProductsWomen's HealthMenopause Hormone Therapy
An FDA advisory committee recommended against approving paroxetine for menopausal vasomotor symptoms. But recognizing the lack of hormone-free products for this indication, and after reviewing the drug's efficacy and safety, the FDA decided it can benefit some women.
| Year | Citations | |
|---|---|---|
Page 1
Page 1